| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/28/2008 | EP1925320A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 05/28/2008 | EP1925319A1 Pharmaceutical compositions containing sc(fv)2 |
| 05/28/2008 | EP1925299A1 Adhesive patch less irritative to skin |
| 05/28/2008 | EP1925297A1 Method for preparing microparticles having a selected polymer molecular weight |
| 05/28/2008 | EP1925294A1 Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
| 05/28/2008 | EP1924633A1 Aqueous polyvinyl acetate dispersions having high shearing stability |
| 05/28/2008 | EP1924293A1 Composition and method for prevention and treatment of type i diabetes |
| 05/28/2008 | EP1924292A2 Compositions and methods for the intraocular transport of therapeutic agents |
| 05/28/2008 | EP1924291A2 Factor xa inhibitor inclusion complex with cyclodextrin |
| 05/28/2008 | EP1924289A2 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 05/28/2008 | EP1924252A2 Method for improving cell permeability to foreign particles |
| 05/28/2008 | EP1924245A2 Topical formulations of histone deacetylase inhibitors and methods of using the same |
| 05/28/2008 | EP1924243A1 Prolonged release formulations comprising anastrozole |
| 05/28/2008 | EP1824531B1 Biomaterials carrying cyclodextrines having improved absorption properties and used for the progressive and delayed release of therapeutic molecules |
| 05/28/2008 | EP1741425B1 Novel antiviral pharmaceutical composition |
| 05/28/2008 | EP1641820B1 Rasgap derived peptide for selectively killing cancer cells |
| 05/28/2008 | EP1620069B1 Warming and nonirritating lubricant fungicide compositions in the form of a gel |
| 05/28/2008 | EP1471895B1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 05/28/2008 | EP1467769B1 Use of a resinate in the preparation of a formulation for smoking cessation |
| 05/28/2008 | EP1438072B1 Polysaccharide-based network and method for the production thereof |
| 05/28/2008 | EP1368063B1 Complex of modafinil and cyclodextrin |
| 05/28/2008 | EP1343483B1 Transdermal system containing a novel high potency progestagen |
| 05/28/2008 | EP1343476B1 Preparation of large liposomes by infusion into peg |
| 05/28/2008 | EP1325035B1 Pharmaceutically acceptable starch and manufacturing process thereof |
| 05/28/2008 | EP1322595B1 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 05/28/2008 | EP1277471B1 Stable liquid preparation comprising sitafloxacin |
| 05/28/2008 | EP1005485B1 Therapeutic pulmonary lavage with diluted surfactants |
| 05/28/2008 | CN101189339A Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 05/28/2008 | CN101189032A Treatment and pre-treatment device comprising nitric oxide and producing method thereof |
| 05/28/2008 | CN101189029A Pharmaceutical dosage forms comprising a lipid phase |
| 05/28/2008 | CN101189024A Stabilised IL-21 compositions |
| 05/28/2008 | CN101189003A Pharmaceutical formulations of HDAC inhibitors |
| 05/28/2008 | CN101186706A Preparation method for PEG series gel nano particles |
| 05/28/2008 | CN101186613A Cytotoxic agents comprising new maytansinoids |
| 05/28/2008 | CN101186286A Method for preparing ordered porous hydroxyapatite material |
| 05/28/2008 | CN101185762A Ciliary neurotrophic factors decorated by polyglycol polymer and preparation method thereof |
| 05/28/2008 | CN101185761A Ephedrine hydrochloride cyclodextrin inclusion compound and its granule preparation method |
| 05/28/2008 | CN101185760A Capsule material formula of soft capsule |
| 05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
| 05/28/2008 | CN101185713A Medicine preparation for treating traumatic injuries and its preparation method and quality control method |
| 05/28/2008 | CN101185711A Nucleus eliminating ointment special for treating hyperplasia of mammary glands |
| 05/28/2008 | CN101185660A Novel technique for producing tincture without diluted ethanol |
| 05/28/2008 | CN101185654A Gemcitabine hydrochloride or gemcitabine composition |
| 05/28/2008 | CN101185653A Breviscapine oral administration composition and preparation method thereof |
| 05/28/2008 | CN101185650A Penciclovir ophthalmic temperature sensitivity in situ gel preparation and preparation method thereof |
| 05/28/2008 | CN101185649A Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 05/28/2008 | CN101185646A Pharmaceutical compositions of amlodipine and atorvastatin |
| 05/28/2008 | CN101185645A Cromoglyn sodium gel eyedrop and preparation method |
| 05/28/2008 | CN101185641A Atorvastatin calcium capsule and preparation method |
| 05/28/2008 | CN101185638A Microemulsion preparation and preparation method thereof |
| 05/28/2008 | CN101185636A Oridonin injection and power injection containing sulfobutyl ether beta-cyclodextrin and preparation method thereof |
| 05/28/2008 | CN101185634A Topotecan sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185633A Neratinib sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185632A Lonafarnib sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185631A Vandetanib sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185630A Temozolomide sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185629A Decitabine sustained-release preparation for treating solid tumor |
| 05/28/2008 | CN101185628A Irinotecan sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185627A Nilotinib sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185626A Marimastat sustained-release implant for treating solid tumor |
| 05/28/2008 | CN101185625A Rubitecan sustained-release implant for treating solid tumor |
| 05/28/2008 | CN100390292C Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/28/2008 | CN100390288C Multivalent antibodies and uses therefor |
| 05/28/2008 | CN100390203C Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 05/28/2008 | CN100390151C 1-N-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 05/28/2008 | CN100389830C Medicinal composition for treating high blood pressure |
| 05/28/2008 | CN100389824C 联合疫苗组合物 Combined vaccine composition |
| 05/28/2008 | CN100389822C Pyridoxal phosphate internally cross-linked hematoglobin nanocapsule and its preparing method |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389791C Eye drops and preparation method thereof |
| 05/28/2008 | CN100389773C Novel helicobacter pylori-binding substances and use thereof |
| 05/28/2008 | CN100389772C Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
| 05/28/2008 | CN100389770C Transparent eye drops containing latanoprost |
| 05/28/2008 | CN100389765C Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 05/28/2008 | CN100389760C Enteric coated drop pills of garlicin, and preparation method |
| 05/28/2008 | CN100389755C Compositions and methods for mucosal delivery |
| 05/28/2008 | CN100389751C Swallow tablet comprising paracetamol |
| 05/28/2008 | CN100389750C Pharmaceutical composition with improved solubility and fluidity |
| 05/27/2008 | US7378469 Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) |
| 05/27/2008 | US7378445 Treatment of prostate cancer |
| 05/27/2008 | US7378408 Methods of treatment and formulations of cephalosporin |
| 05/27/2008 | US7378405 Adding an omega-3 acid for stabilizing a formulation including hydrocortisone 17-butyrate |
| 05/27/2008 | US7378394 Sustained-release microparticle preparation of human growth hormone and process for producing thereof |
| 05/27/2008 | US7378387 Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes |
| 05/27/2008 | US7378108 Percutaneous absorption preparation of compound having angiotensin II antagonistic activity |
| 05/27/2008 | US7378107 administering triglycerides such as triester of caprylic acid or capric acid with glycerin, used along with foods or drugs, without concerning about side effects and restrictive diets |
| 05/27/2008 | US7378102 Diclofenac sodium oral pharmaceutical |
| 05/27/2008 | US7378097 Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant |
| 05/27/2008 | US7378096 biodrugs comprising heat shock protein or glucose-regulated proteins complexed with immuogens including glycoproteins, her2/neu proteins or tuberculosis antigens, and carriers, used as anticarcinogenic agents |
| 05/27/2008 | CA2438170C Modulated release particles for aerosol delivery |
| 05/27/2008 | CA2413629C Solid method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/27/2008 | CA2345064C Fentanyl composition for the treatment of acute pain |
| 05/27/2008 | CA2319100C Microparticle inhalation formulations |
| 05/27/2008 | CA2256960C High glycerin containing anti-microbial cleansers |
| 05/27/2008 | CA2120358C Hormone analogs with multiple ctp extensions |
| 05/22/2008 | WO2008061078A2 Matrix-embedded compositions having organic acids and fatty acids |
| 05/22/2008 | WO2008061020A2 Methods of treating, diagnosing or detecting cancer |
| 05/22/2008 | WO2008060546A2 Oral formulations |
| 05/22/2008 | WO2008060515A2 Topical compositions comprising polyhydroxy acids and/or lactones for improved cutaneous effects of oxidative therapeutic drugs |
| 05/22/2008 | WO2008060367A2 Human antibodies that bind cxcr4 and uses thereof |